Brighter and lighter days ahead
Sooma tDCS™ – accessible, safe, and effective brain stimulation treatment for depression and chronic pain. Easy solution for optimized patiet care and flows.
Sooma Depression Treatment
Effective care for depression made accessible
Depression is a worldwide public health problem which overwhelms millions of people across age groups and backgrounds – and most are still waiting in line to access care. Sooma tDCS™ is a pioneering, safe, and scientifically proven brain stimulation treatment for both in-clinic and at-home treatment of depression. It’s a seamless remote solution that enables delivering better mental health to more patients in less time.
Contact us
Don’t hesitate to contact us with any questions you might have about Sooma products, the technology, or our company.
Image and content
Treating depression where it happens
Sooma tDCS™ is a groundbreaking and proven effective brain stimulation treatment which is used by licensed clinicians around the world. Developed in cooperation with medical professionals and health tech engineers, Sooma tDCS™ is both noninvasive and drug-free, and can be used either as a first-line of treatment or to bring additive effects to other forms of treatment. With regular daily use, most patients experience relief in their symptoms already after the first three weeks.
FAQ section lorem ipsum
Mauris sed libero. Suspendisse facilisis nulla in lacinia laoreet, lorem velit accumsan velit vel mattis libero nisl et sem. Proin interdum maecenas massa turpis sagittis in, interdum non lobortis vitae massa. Quisque purus lectus, posuere eget imperdiet nec sodales id arcu. Vestibulum elit pede dictum eu, viverra non tincidunt eu ligula.
Mauris sed libero. Suspendisse facilisis nulla in lacinia laoreet, lorem velit accumsan velit vel mattis libero nisl et sem. Proin interdum maecenas massa turpis sagittis in, interdum non lobortis vitae massa. Quisque purus lectus, posuere eget imperdiet nec sodales id arcu. Vestibulum elit pede dictum eu, viverra non tincidunt eu ligula.
Mauris sed libero. Suspendisse facilisis nulla in lacinia laoreet, lorem velit accumsan velit vel mattis libero nisl et sem. Proin interdum maecenas massa turpis sagittis in, interdum non lobortis vitae massa. Quisque purus lectus, posuere eget imperdiet nec sodales id arcu. Vestibulum elit pede dictum eu, viverra non tincidunt eu ligula.
Mauris sed libero. Suspendisse facilisis nulla in lacinia laoreet, lorem velit accumsan velit vel mattis libero nisl et sem. Proin interdum maecenas massa turpis sagittis in, interdum non lobortis vitae massa. Quisque purus lectus, posuere eget imperdiet nec sodales id arcu. Vestibulum elit pede dictum eu, viverra non tincidunt eu ligula.
asd
asd
- asd
- asd
Care through a current
Sooma tDCS™ is based on transcranial direct current stimulation (tDCS), an innovative therapy that is back by decades of research. It works by way of a small portable medical device, which is used in 30-minute sessions to safely deliver a weak electrical current to the dorsolateral prefrontal cortex (DLPFC).
tDCS is a safe treatment method that is not associated with any serious adverse effects, as established in a safety review based on over 40,000 stimulation sessions. To ensure appropriate usage as well as continuous progress and health monitoring, Sooma tDCS is always prescribed by a medical professional.
Icon list inside image and content
What is Sooma tDCS™?
Sooma tDCS™ combines pioneering brain stimulation technology with remote protocol management in one easy-to-use system for scalable treatment of depression and chronic pain.
Delivered through a portable device, the treatment utilizes transcranial direct current stimulation (tDCS) to relieve symptoms, with online treatment monitoring and adjustments for quick data-driven clinical decisions. It’s noninvasive, drug-free, and proven effective.
Accordion
Mauris sed libero. Suspendisse facilisis nulla in lacinia laoreet, lorem velit accumsan velit vel mattis libero nisl et sem. Proin interdum maecenas massa turpis sagittis in, interdum non lobortis vitae massa. Quisque purus lectus, posuere eget imperdiet nec sodales id arcu. Vestibulum elit pede dictum eu, viverra non tincidunt eu ligula.
Mauris sed libero. Suspendisse facilisis nulla in lacinia laoreet, lorem velit accumsan velit vel mattis libero nisl et sem. Proin interdum maecenas massa turpis sagittis in, interdum non lobortis vitae massa. Quisque purus lectus, posuere eget imperdiet nec sodales id arcu. Vestibulum elit pede dictum eu, viverra non tincidunt eu ligula.
Mauris sed libero. Suspendisse facilisis nulla in lacinia laoreet, lorem velit accumsan velit vel mattis libero nisl et sem. Proin interdum maecenas massa turpis sagittis in, interdum non lobortis vitae massa. Quisque purus lectus, posuere eget imperdiet nec sodales id arcu. Vestibulum elit pede dictum eu, viverra non tincidunt eu ligula.
Mauris sed libero. Suspendisse facilisis nulla in lacinia laoreet, lorem velit accumsan velit vel mattis libero nisl et sem. Proin interdum maecenas massa turpis sagittis in, interdum non lobortis vitae massa. Quisque purus lectus, posuere eget imperdiet nec sodales id arcu. Vestibulum elit pede dictum eu, viverra non tincidunt eu ligula.
Map
Sooma tDCS™ clinics worldwide
Sooma tDCS™ treatment is available in more than 35 countries across four continents.
Quote with author
“Normal quote without author text-510”
“Normal quote without author”
Quote carousel group
Hear it from others
Sooma tDCS™ has helped more than 20,00 patients find relief and a better quality of life in more than 35 countries worldwide. But don’t just take our word for it – read what clinicians and patients have to say about the many benefits of our noninvasive and hypermodern brain stimulation treatment.
Carousel group
Instructions about the treatment
Lacinia quis facilisis sed sapien. Mauris varius diam vitae arcu. Sed arcu lectus auctor vitae, consectetuer et venenatis eget velit. Sed augue orci.
Background boxes
Brochure for Patients
Quick Start Guide
asd
Background boxes after image and content
Add from block list patterns tab
Modern-day health care – in clinic or at home
Specifically designed for both in-clinic and at-home treatment, Sooma pairs tDCS with an easy-to-use secure system for informed treatment decisions and remote care.
The Sooma Clinician Portal allows customizing and tracking patient protocols via treatment logs, patient-reported outcomes, and dosage reports, while patients are guided through each session by the Sooma App.
The system communicates seamlessly with the Sooma device for easy patient-administered treatment sessions and comes with built-in adherence and monitoring capabilities – for cull clinician control.
Sooma Clinician Portal
Apple iOS application
Android application
Title and content
A short history of Sooma
Sooma Medical (Sooma Oy) is a Finnish medical device manufacturer established in 2013. With headquarters in Helsinki, Finland, we work at the core of medical research and technology to deliver effective treatment solutions for psychiatric and neurophysiological conditions that affect and inhibit millions of people all over the world.
Grounded in science, our solutions are developed in close cooperation with leading experts in psychiatry and clinical neurophysiology – as they have been from day one. All Sooma tDCS medical devices are manufactured in Finland in accordance with the ISO 13485 standard for Quality Management Systems for Medical Devices, ensuring the highest possible quality for clinicians and patients alike.
Our first solution was launched in 2014 with the debut of Sooma tDCS, the first generation of our brain stimulation treatment for Major Depressive Disorder. In 2017, our product portfolio expanded further to pain management as Sooma tDCS was approved for the treatment for fibromyalgia, chronic neuropathic pain, and other long-term pain conditions.
Today, we collaborate with more than 150 clinics, universities, and hospitals worldwide to provide them with a state-of-the-art neuromodulation devices for both research purposes and patient care. We are proud to be able to say that, since 2013, Sooma treatments have helped more than 20,000 patients find relief in more than 30 countries, with more than 100,000 treatment sessions successfully administered.
Logowall
Sooma tDCS™ treatment is available in more than 35 countries across four continents.
Centered numbers
2014
Launch of Sooma Depression Treatment and Sooma tDCS
2014
Class Ila CE marking (Depression)
2015
Malaysian Medical Device Authority (MDA) approval
2016
Australian TGA (Therapeutic Goods Administration) approval
2016
Health Canada (Chronic Pain Class III) approval
2017
Launch of Sooma Pain Management for Chronic Pain
2017
Singapre HSA (Health Science Authority) approval
2017
CE marking (Chronic Pain)
2017
Turkey (Depression)
2018
Mexican COFEPRIS (Federal Commission for Protection Against Health Risks) approval
2019
Indonesia (Depression)
Centered icons
(When adding a new item, you need to replace heading block to image block manually)
High-quality care with low-threshold access
Relieving symptoms – without generating new ones
Safe and effective treatment without fear of dependency
Better quality of life for everyone, every day, everywhere
Better quality of life for everyone, every day, everywhere
Better quality of life for everyone, every day, everywhere
Centered icons and titles
(When adding a new item, you need to add image block manually)
Faster clinical response
Decreased symptoms for most patients in just three weeks
Increased patient flows
Increased patient flows
Safe, effective, and affordable
Access to safe, effective and noninvasive care through low-cost equipment
Easy adoption
Simple treatment protocols with easily absorbed user materials and training.